Frontlight ResearchEarly access
Trial site
Segeberger Kliniken GmbH
- 11running trials
The trials here
What the 11 trials at this site are about, from their registry records.
- Conditions
- Coronary artery disease6 trials
- Heart failure3 trials
- Obesity2 trials
- Aortic stenosis1 trial
- Atrial fibrillation1 trial
- High blood pressure1 trial
- Stroke1 trial
- Phase
- Phase 33 trials
- Status
- Active, not recruiting7 trials
- Recruiting4 trials
- Lead sponsor
- Abbott Medical Devices1 trial
- Amgen1 trial
- Amgen Inc.1 trial
- Biosensors Europe SA1 trial
- Bolt Medical1 trial
- and 6 more
Running trials
Recruiting
SGLT2 Inhibition for Cardiovascular Endpoint Reduction in Hypertension
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Prevention Of Sudden Cardiac Death After Myocardial Infarction by Defibrillator Implantation
Active, not recruiting
The Elixir Bioadaptor vs. The Onyx Stent in De Novo Native Coronary Arteries
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Heart failure2 recruiting
- Obesity2 recruiting
- Coronary artery disease1 recruiting
- High blood pressure1 recruiting
Site data: ClinicalTrials.govUpdated 13 Nov 2026